Dominant-negative effect of hetero-oligomerization on the function of the human immunodeficiency virus type 1 envelope glycoprotein complex. 2006

Carolina Herrera, and Per Johan Klasse, and Christopher W Kibler, and Elizabeth Michael, and John P Moore, and Simon Beddows
Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY 10021, USA.

The human immunodeficiency virus type 1 (HIV-1) envelope (Env) glycoprotein forms trimers that mediate interactions with the CD4 receptor and a co-receptor on the target cell surface, thereby triggering viral fusion with the cell membrane. Cleavage of Env into its surface, gp120, and transmembrane, gp41, moieties is necessary for activation of its fusogenicity. Here, we produced pseudoviruses with phenotypically mixed wild-type (Wt) and mutant, cleavage-incompetent Env in order to quantify the effects of incorporating uncleaved Env on virion infectivity, antigenicity and neutralization sensitivity. We modeled the relative infectivity of three such phenotypically mixed viral strains, JR-FL, HXBc2 and a derivative of the latter, 3.2P, as a function of the relative amount of Wt Env. The data were fit very closely (R(2) > 0.99) by models which assumed that only Wt homotrimers were functional, with different approximate thresholds of critical numbers of functional trimers per virion for the three strains. We also produced 3.2P pseudoviruses containing both a cleavage-competent Env that is defective for binding the neutralizing monoclonal antibody (NAb) 2G12, and a cleavage-incompetent Env that binds 2G12. The 2G12 NAb was not able to reduce the infectivity of these pseudoviruses detectably. Their neutralization by the CD4-binding site-directed agents CD4-IgG2 and NAb b12 was also unaffected by 2G12 binding to uncleaved Env. These results further strengthen the conclusion that only homotrimers consisting of cleaved Env are functional. They also imply that the function of a trimer is unaffected sterically by the binding of an antibody to an adjacent trimer.

UI MeSH Term Description Entries
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005799 Genes, Dominant Genes that influence the PHENOTYPE both in the homozygous and the heterozygous state. Conditions, Dominant Genetic,Dominant Genetic Conditions,Genetic Conditions, Dominant,Condition, Dominant Genetic,Dominant Gene,Dominant Genes,Dominant Genetic Condition,Gene, Dominant,Genetic Condition, Dominant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015699 HIV Envelope Protein gp120 External envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 120 kDa and contains numerous glycosylation sites. Gp120 binds to cells expressing CD4 cell-surface antigens, most notably T4-lymphocytes and monocytes/macrophages. Gp120 has been shown to interfere with the normal function of CD4 and is at least partly responsible for the cytopathic effect of HIV. Envelope Glycoprotein gp120, HIV,HTLV-III gp120,env Protein gp120, HIV,gp120(HIV),HIV Envelope Glycoprotein gp120,gp120 Envelope Glycoprotein, HIV,HTLV III gp120,gp120, HTLV-III
D015700 HIV Envelope Protein gp41 Transmembrane envelope protein of the HUMAN IMMUNODEFICIENCY VIRUS which is encoded by the HIV env gene. It has a molecular weight of 41,000 and is glycosylated. The N-terminal part of gp41 is thought to be involved in CELL FUSION with the CD4 ANTIGENS of T4 LYMPHOCYTES, leading to syncytial formation. Gp41 is one of the most common HIV antigens detected by IMMUNOBLOTTING. Envelope Protein gp41, HIV,HIV Transmembrane Protein gp41,HTLV-III gp41,env Protein gp41, HIV,gp41(HIV),gp41 Envelope Protein, HIV
D020836 Protein Structure, Quaternary The characteristic 3-dimensional shape and arrangement of multimeric proteins (aggregates of more than one polypeptide chain). Quaternary Protein Structure,Protein Structures, Quaternary,Quaternary Protein Structures

Related Publications

Carolina Herrera, and Per Johan Klasse, and Christopher W Kibler, and Elizabeth Michael, and John P Moore, and Simon Beddows
January 1990, Proceedings of the National Academy of Sciences of the United States of America,
Carolina Herrera, and Per Johan Klasse, and Christopher W Kibler, and Elizabeth Michael, and John P Moore, and Simon Beddows
February 2000, Virology,
Carolina Herrera, and Per Johan Klasse, and Christopher W Kibler, and Elizabeth Michael, and John P Moore, and Simon Beddows
March 1997, Journal of virology,
Carolina Herrera, and Per Johan Klasse, and Christopher W Kibler, and Elizabeth Michael, and John P Moore, and Simon Beddows
February 1995, Journal of virology,
Carolina Herrera, and Per Johan Klasse, and Christopher W Kibler, and Elizabeth Michael, and John P Moore, and Simon Beddows
September 1992, AIDS research and human retroviruses,
Carolina Herrera, and Per Johan Klasse, and Christopher W Kibler, and Elizabeth Michael, and John P Moore, and Simon Beddows
February 1995, Journal of virology,
Carolina Herrera, and Per Johan Klasse, and Christopher W Kibler, and Elizabeth Michael, and John P Moore, and Simon Beddows
September 1987, Science (New York, N.Y.),
Carolina Herrera, and Per Johan Klasse, and Christopher W Kibler, and Elizabeth Michael, and John P Moore, and Simon Beddows
January 1996, Intervirology,
Carolina Herrera, and Per Johan Klasse, and Christopher W Kibler, and Elizabeth Michael, and John P Moore, and Simon Beddows
July 1993, Journal of virology,
Carolina Herrera, and Per Johan Klasse, and Christopher W Kibler, and Elizabeth Michael, and John P Moore, and Simon Beddows
July 1996, The Journal of general virology,
Copied contents to your clipboard!